New approval: Trabectedin (Yondells®) now for the treatment of ovarian cancer.

被引：0
|
作者：
不详
机构：
来源：
ONKOLOGIE | 2010年 / 33卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：130 / 130
页数：1
相关论文
共 50 条
  • [1] Trabectedin in Ovarian Cancer: is it now a Standard of Care?
    Ventriglia, J.
    Paciolla, I.
    Cecere, S. C.
    Pisano, C.
    Di Napoli, M.
    Arenare, L.
    Setola, S. V.
    Losito, N. S.
    Califano, D.
    Orditura, M.
    Pignata, S.
    CLINICAL ONCOLOGY, 2018, 30 (08) : 498 - 503
  • [2] Trabectedin as a New Chemotherapy Option in the Treatment of Relapsed Platinum Sensitive Ovarian Cancer
    Monk, Bradley J.
    Dalton, Heather
    Benjamin, Ivor
    Tanovic, Adnan
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (25) : 3754 - 3769
  • [3] Trabectedin in ovarian cancer
    Colombo, Nicolletta
    Mancari, Rosanna
    EJHP PRACTICE, 2010, 16 (03): : 65 - 67
  • [4] New treatment for patients with advanced ovarian cancer receives accelerated approval
    Printz, Carrie
    CANCER, 2017, 123 (08) : 1286 - 1287
  • [5] Comorbidity and treatment for ovarian cancer.
    O'Malley, CD
    Cress, R
    West, D
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 153 (11) : S112 - S112
  • [6] Trabectedin for the therapy of ovarian cancer
    Evangelisti, G.
    Barra, F.
    D'Alessandro, G.
    Tantari, M.
    Stigliani, S.
    Della Corte, L.
    Bifulco, G.
    Ferrero, S.
    DRUGS OF TODAY, 2020, 56 (10) : 669 - 688
  • [7] Clinical utility of trabectedin for the treatment of ovarian cancer: current evidence
    Mascilini, Floriana
    Amadio, Giulia
    Di Stefano, Maria Grazia
    Ludovisi, Manuela
    Di Legge, Alessia
    Conte, Carmine
    De Vincenzo, Rosa
    Ricci, Caterina
    Masciullo, Valeria
    Salutari, Vanda
    Scambia, Giovanni
    Ferrandina, Gabriella
    ONCOTARGETS AND THERAPY, 2014, 7 : 1273 - 1284
  • [8] Targeting micrometastasis for the treatment of ovarian cancer.
    Ahmed, Ahmed Ashour
    CLINICAL CANCER RESEARCH, 2018, 24 (15) : 18 - 18
  • [9] Targeted approaches to the treatment of ovarian cancer.
    Dressman, Holly K.
    Lancaster, Johnathan M.
    Chan, Gina
    Cragun, Janiel M.
    Bild, Andrea
    Sayer, Robyn
    Clarke, Jennifer
    Marks, Jeffrey
    Potti, Anil
    Nevins, Joseph R.
    Berchuck, Andrew
    CANCER RESEARCH, 2006, 66 (08)
  • [10] The efficacy of trabectedin in treating ovarian cancer
    Teplinsky, Eleonora
    Herzog, Thomas J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (03) : 313 - 323
12345